Literature DB >> 12067330

Anti-GM1 ganglioside antibodies in Parkinson's disease.

M Zappia1, L Crescibene, D Bosco, G Arabia, G Nicoletti, A Bagalà, L Bastone, I D Napoli, M Caracciolo, S Bonavita, A Di Costanzo, A Gambardella, A Quattrone.   

Abstract

OBJECTIVES: To determine whether anti-GM1 antibodies are increased in Parkinson's disease (PD).
METHODS: Serum immunoglobulin M (IgM) and IgG anti-GM1 antibodies were detected by enzyme-linked immunosorbent assay (ELISA) in 147 patients with PD and in 186 age-matched normal control subjects. Sera were assayed at initial dilution of 1:800 for IgM and 1:200 for IgG and were considered positive at absorbance values exceeding the value of 0.05 for IgM and 0.1 for IgG.
RESULTS: Forty patients with PD (27.2%) had sera positive for IgM anti-GM1 antibodies, whereas only five normal controls (2.7%) resulted positive (P < 0.0001). Most of patients (75%) with positive sera had a tremor-dominant form of PD. Only two patients with PD (1.4%) and none of normal controls had sera positive for IgG anti-GM1 antibodies.
CONCLUSION: A consistent portion of parkinsonians, mainly with a tremor-dominant form of PD, may have increased circulating IgM anti-GM1 antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067330     DOI: 10.1034/j.1600-0404.2002.01240.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  19 in total

Review 1.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 3.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

Review 4.  Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner.

Authors:  Wenbin Liu; Meiyang Fan; Wen Lu; Wenhua Zhu; Liesu Meng; Shemin Lu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 5.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

6.  Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.

Authors:  Jianshe Wei; Masayo Fujita; Masaaki Nakai; Masaaki Waragai; Akio Sekigawa; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 7.  Autoimmunity, dendritic cells and relevance for Parkinson's disease.

Authors:  E Koutsilieri; M B Lutz; C Scheller
Journal:  J Neural Transm (Vienna)       Date:  2012-06-15       Impact factor: 3.575

Review 8.  Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases.

Authors:  Jacques Fantini; Nouara Yahi
Journal:  Expert Rev Mol Med       Date:  2010-09-01       Impact factor: 5.600

9.  Medical management of Parkinson's disease: focus on neuroprotection.

Authors:  Marie-Catherine Boll; Mireya Alcaraz-Zubeldia; Camilo Rios
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

10.  Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.

Authors:  Toshio Ariga; Masaru Kubota; Makoto Nakane; Kenji Oguro; Robert K Yu; Susumu Ando
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.